Prognostic Value of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Systemic Immune-Inflammatory Index in Resected Gastric Cancer

<b>Objective:&nbsp;</b>The prognostic value of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and systemic immune-inflammatory index has been studied in many cancer types. Our aim is to show the prognostic value of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and sy...

Full description

Bibliographic Details
Main Authors: Hayriye Şahinli, Sema Türker
Format: Article
Language:English
Published: National Scientific Medical Center 2019-12-01
Series:Ķazaķstannyṇ Klinikalyķ Medicinasy
Subjects:
Online Access:https://www.clinmedkaz.org/download/prognostic-value-of-neutrophil-lymphocyte-ratio-platelet-lymphocyte-ratio-and-systemic-9076.pdf
_version_ 1818501604269096960
author Hayriye Şahinli
Sema Türker
author_facet Hayriye Şahinli
Sema Türker
author_sort Hayriye Şahinli
collection DOAJ
description <b>Objective:&nbsp;</b>The prognostic value of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and systemic immune-inflammatory index has been studied in many cancer types. Our aim is to show the prognostic value of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and systemic immune-inflammatory index in resected gastric cancer patients. In addition, to determine which parameter is a better predictor of survival.<br> <b>Material and methods:</b>&nbsp;The study included 95 patients resected gastric cancer between 2014-2018. Receiver operating curve analysis was used to determine neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and systemic immune-inflammatory index cut-off values. Systemic immune-inflammatory index was evaluated as neutrophil × platelet/lymphocyte. Long rank and cox regression analysis were used.<br> <b>Results:&nbsp;</b>The median age was 62 (22-84) years. The median overall survival was 33 months. 49 (51.6%) patients were in stage 3 and 46 (48.4 %) patients were in stage 1-2. High neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and systemic immune-inflammatory index values, tumor depth, stage of metastatic lymph node and tumor-node-metastasis stage were poor prognostic factors for overall survival and disease-free survival. When multivariant cox regression analysis was performed, only platelet-lymphocyte ratio was found to be independent prognostic factor (p = 0.037 for overall survival, p = 0.024 for overall survival).<br> <b>Conclusion</b>: High neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and systemic immune-inflammatory index were found to be poor prognostic factors in predicting both overall survival and disease-free survival before treatment in patients who undergo curative resection for gastric cancer. As a result of multivariant analysis, only high platelet-lymphocyte ratio was determined as an independent poor prognostic factor for both overall survival and disease-free survival.
first_indexed 2024-12-10T20:58:34Z
format Article
id doaj.art-3677bfa19c794fa48bdc72f17374fec3
institution Directory Open Access Journal
issn 1812-2892
2313-1519
language English
last_indexed 2024-12-10T20:58:34Z
publishDate 2019-12-01
publisher National Scientific Medical Center
record_format Article
series Ķazaķstannyṇ Klinikalyķ Medicinasy
spelling doaj.art-3677bfa19c794fa48bdc72f17374fec32022-12-22T01:33:52ZengNational Scientific Medical CenterĶazaķstannyṇ Klinikalyķ Medicinasy1812-28922313-15192019-12-01454343910.23950/1812-2892-JCMK-00724Prognostic Value of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Systemic Immune-Inflammatory Index in Resected Gastric CancerHayriye Şahinli0Sema Türker1Department of Medical Oncology, Ankara Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, TurkeyDepartment of Medical Oncology, Ankara Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey<b>Objective:&nbsp;</b>The prognostic value of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and systemic immune-inflammatory index has been studied in many cancer types. Our aim is to show the prognostic value of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and systemic immune-inflammatory index in resected gastric cancer patients. In addition, to determine which parameter is a better predictor of survival.<br> <b>Material and methods:</b>&nbsp;The study included 95 patients resected gastric cancer between 2014-2018. Receiver operating curve analysis was used to determine neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and systemic immune-inflammatory index cut-off values. Systemic immune-inflammatory index was evaluated as neutrophil × platelet/lymphocyte. Long rank and cox regression analysis were used.<br> <b>Results:&nbsp;</b>The median age was 62 (22-84) years. The median overall survival was 33 months. 49 (51.6%) patients were in stage 3 and 46 (48.4 %) patients were in stage 1-2. High neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and systemic immune-inflammatory index values, tumor depth, stage of metastatic lymph node and tumor-node-metastasis stage were poor prognostic factors for overall survival and disease-free survival. When multivariant cox regression analysis was performed, only platelet-lymphocyte ratio was found to be independent prognostic factor (p = 0.037 for overall survival, p = 0.024 for overall survival).<br> <b>Conclusion</b>: High neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and systemic immune-inflammatory index were found to be poor prognostic factors in predicting both overall survival and disease-free survival before treatment in patients who undergo curative resection for gastric cancer. As a result of multivariant analysis, only high platelet-lymphocyte ratio was determined as an independent poor prognostic factor for both overall survival and disease-free survival.https://www.clinmedkaz.org/download/prognostic-value-of-neutrophil-lymphocyte-ratio-platelet-lymphocyte-ratio-and-systemic-9076.pdfgastric cancerneutrophil-lymphocyte ratioplatelet-lymphocyte ratioprognosis
spellingShingle Hayriye Şahinli
Sema Türker
Prognostic Value of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Systemic Immune-Inflammatory Index in Resected Gastric Cancer
Ķazaķstannyṇ Klinikalyķ Medicinasy
gastric cancer
neutrophil-lymphocyte ratio
platelet-lymphocyte ratio
prognosis
title Prognostic Value of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Systemic Immune-Inflammatory Index in Resected Gastric Cancer
title_full Prognostic Value of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Systemic Immune-Inflammatory Index in Resected Gastric Cancer
title_fullStr Prognostic Value of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Systemic Immune-Inflammatory Index in Resected Gastric Cancer
title_full_unstemmed Prognostic Value of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Systemic Immune-Inflammatory Index in Resected Gastric Cancer
title_short Prognostic Value of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Systemic Immune-Inflammatory Index in Resected Gastric Cancer
title_sort prognostic value of neutrophil lymphocyte ratio platelet lymphocyte ratio and systemic immune inflammatory index in resected gastric cancer
topic gastric cancer
neutrophil-lymphocyte ratio
platelet-lymphocyte ratio
prognosis
url https://www.clinmedkaz.org/download/prognostic-value-of-neutrophil-lymphocyte-ratio-platelet-lymphocyte-ratio-and-systemic-9076.pdf
work_keys_str_mv AT hayriyesahinli prognosticvalueofneutrophillymphocyteratioplateletlymphocyteratioandsystemicimmuneinflammatoryindexinresectedgastriccancer
AT sematurker prognosticvalueofneutrophillymphocyteratioplateletlymphocyteratioandsystemicimmuneinflammatoryindexinresectedgastriccancer